Magnetic resonance imaging (MRI) evaluation of pathologically residual tumors in breast cancer after neoadjuvant chemotherapy: experience of 2 centres in Spain

被引：0
|
作者：
Luque, M. [1 ]
Sampedro, T. [2 ]
Garcia-Teijido, P. [2 ]
Fernandez, Y. [3 ]
Izquierdo, M. [1 ]
Diaz, A. [1 ]
Nava, E. [1 ]
Menendez, P. [1 ]
Serrano, S. [4 ]
Maria, L. [1 ]
机构：
[1] Univ Gen Hosp Asturias, Oviedo, Spain
[2] Hosp San Agustin, Aviles, Spain
[3] Univ Gen Hosp Asturias, Aviles, Spain
[4] Hosp San Agustin, Oviedo, Spain
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(10)70073-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：70 / 71
页数：2
相关论文
共 50 条
  • [41] Breast cancer and magnetic resonance imaging (MRI): Background parenchymal enhancement (BPE) predicting response to neoadjuvant chemotherapy (NAC)
    Campos Teixeira, Sandra Regina
    Amancio de Camargo, Helio Sebastiao
    Ramalho, Susana
    Natal, Rodrigo
    Machado, Helymar da Costa
    Amancio de Camargo, Marcia Martos
    Azevedo, Juliana
    Arruda, Mauricio da Souza
    Solla Negrao, Erika Marina
    Almeida, Natali Rios
    Teixeira, Ana Luiza
    Cabello, Vitor
    Cabello, Cesar
    CANCER RESEARCH, 2018, 78 (04)
  • [42] Magnetic Resonance Imaging Evaluation of Noninflammatory Breast Cancer with Skin Involvement After Neoadjuvant Chemotherapy (vol 17, pg 1964, 2010)
    Chen, Jeon-Hor
    Mehta, Rita S.
    Nalcioglu, O.
    Su, M. -Y.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 : S329 - S329
  • [43] Factors associated with radiologic-pathologic discordance in magnetic resonance imaging after neoadjuvant chemotherapy for breast cancer
    Kwon, Mi-ri
    Chu, Jinah
    Kook, Shin Ho
    Kim, Eun Young
    CLINICAL IMAGING, 2022, 89 : 1 - 9
  • [44] Prediction of Pathologic Complete Response by Ultrasonography and Magnetic Resonance Imaging After Neoadjuvant Chemotherapy in Patients with Breast Cancer
    Zhang, Kai
    Li, Jiawei
    Zhu, Qian
    Chang, Cai
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 2603 - 2612
  • [45] Multiparametric Magnetic Resonance Imaging for Predicting Pathological Response After the First Cycle of Neoadjuvant Chemotherapy in Breast Cancer
    Li, Xia
    Abramson, Richard G.
    Arlinghaus, Lori R.
    Kang, Hakmook
    Chakravarthy, Anuradha Bapsi
    Abramson, Vandana G.
    Farley, Jaime
    Mayer, Ingrid A.
    Kelley, Mark C.
    Meszoely, Ingrid M.
    Means-Powell, Julie
    Grau, Ana M.
    Sanders, Melinda
    Yankeelov, Thomas E.
    INVESTIGATIVE RADIOLOGY, 2015, 50 (04) : 195 - 204
  • [46] Imaging evaluation of pathological response in breast cancer after neoadjuvant chemotherapy by real-time sonoelastography and MRI
    Bando, H.
    Tohno, E.
    Katayama, H.
    Hara, H.
    Yashiro, T.
    Noguchi, M.
    Ueno, E.
    EJC SUPPLEMENTS, 2008, 6 (07): : 66 - 67
  • [47] Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT
    An, Yeong Yi
    Kim, Sung Hun
    Kang, Bong Joo
    Lee, Ah Won
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (06) : 808 - 815
  • [48] Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype
    Fukuda, Takayo
    Horii, Rie
    Gomi, Naoya
    Miyagi, Yumi
    Takahashi, Shunji
    Ito, Yoshinori
    Akiyama, Futoshi
    Ohno, Shinji
    Iwase, Takuji
    SPRINGERPLUS, 2016, 5 : 1 - 9
  • [49] ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy
    Veys, Isabelle
    Pop, Catalin-Florin
    Barbieux, Romain
    Moreau, Michel
    Noterman, Danielle
    De Neubourg, Filip
    Nogaret, Jean-Marie
    Liberale, Gabriel
    Larsimont, Denis
    Bourgeois, Pierre
    PLOS ONE, 2018, 13 (05):
  • [50] Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype
    Loo, Claudette E.
    Straver, Marieke E.
    Rodenhuis, Sjoerd
    Muller, Sara H.
    Wesseling, Jelle
    Peeters, Marie-Jeanne T. F. D. Vrancken
    Gilhuijs, Kenneth G. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (06) : 660 - 666
12345